SAN DIEGO, Sept. 2, 2014 /PRNewswire/ -- Sequenom, Inc.
(NASDAQ: SQNM), a life sciences company providing innovative
genetic analysis solutions, today announced the Company's
participation at the 2014 Morgan Stanley Global Healthcare
Conference at the Grand Hyatt in New
York, NY on September 8 -10,
2014.
William Welch, Chief Executive
Officer, and Carolyn Beaver, Chief
Financial Officer, will present on Monday,
September 8, beginning at 9:20 a.m.
ET to provide an overview of and update on the Company. The
presentation is expected to last approximately 30 minutes and will
be webcast live through the "Invest" section of the Sequenom Web
site at www.sequenom.com. An audio replay will be available for 30
days following the initial broadcast.
About Sequenom
Sequenom, Inc. (NASDAQ: SQNM) is a life
sciences company committed to improving health care through
revolutionary genomic and genetic analysis solutions. Sequenom
develops innovative technologies, products, and diagnostic tests
that target and serve molecular diagnostic markets. Web site:
www.sequenom.com
Logo - http://photos.prnewswire.com/prnh/20040415/SQNMLOGO
SOURCE Sequenom, Inc.